Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection - A pilot study
Fj. Kridelka et al., Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection - A pilot study, CANCER, 86(10), 1999, pp. 2059-2065
BACKGROUND. After radical hysterectomy and pelvic lymph node dissection, an
identifiable subgroup of patients with International Federation of Gynecol
ogy and Obstetrics Stage IB lymph node negative cervix carcinoma remains at
high risk of pelvic recurrence. This study attempted to determine whether
postoperative small field of pelvic radiation can improve the disease free
survival (DFS) of this high risk group of patients without producing signif
icant morbidity.
METHODS. Between 1991 and 1995, after radical surgery, 25 patients with Sta
ge IB lymph node negative cervix carcinoma were considered to be at high ri
sk of pelvic recurrence on the basis of tumor dimension, depth of stromal i
nvasion, and the presence of lymph-vascular space invasion. All had a score
greater than or equal to 120 as determined by the Gynecologic Oncology Gro
up (GOG) study. These patients received 50.4 gray of adjuvant radiation to
a small central pelvic field and were followed prospectively. A Kaplan-Meie
r 5-year DFS curve was generated. A log rank analysis produced an estimated
log rank P value (est P value) by comparing the 5-year DFS of the patients
in the current study with the 5-year DFS of the corresponding high risk gr
oup of the GOG study (observation only). The morbidity of small field pelvi
c radiation was recorded.
RESULTS. Among the 25 patients who received small field pelvic radiation, t
he mean GOG score was 166 (range, 120-263) and the mean follow-up was 32 mo
nths (range, 12-64 months). There was 1 recurrence (4%) recorded at 16 mont
hs. The log rank analysis demonstrated a significant improvement in the 5-y
ear DFS for the group who received adjuvant small field pelvic radiation (e
st P value = 0.005) when compared with the DFS of the high risk GOG patient
s who were observed postoperatively. Four cases of minor morbidity were rec
orded: lymphedema (three cases) and mild rectal incontinence (one case). No
major morbidity was reported.
CONCLUSIONS. With low morbidity, adjuvant small field pelvic radiation appe
ars to improve significantly the 5-year DFS of patients with high risk, lym
ph node negative Stage IB cervical carcinoma. However, this pilot study req
uires verification. Cancer 1999;86:2059-65. (C) 1999 American Cancer Societ
y.